Skip to main content
Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
30.24
-1.52 (-4.79%)
Nov 13, 2026, 11:35 AM EST - Market open

Alamar Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Market Capitalization
2,101--
Market Cap Growth
---
Enterprise Value
1,917--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Debt / Equity Ratio
0.140.550.33
Net Debt / Equity Ratio
-0.610.15-0.45
Net Debt / EBITDA Ratio
4.16-0.400.98
Net Debt / FCF Ratio
2.69-0.190.80
Asset Turnover
-0.51-
Inventory Turnover
-1.23-
Quick Ratio
7.411.805.23
Current Ratio
9.493.996.43
Return on Equity (ROE)
--33.58%-
Return on Assets (ROA)
--13.53%-
Return on Capital Employed (ROCE)
-13.90%-27.00%-37.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Buyback Yield / Dilution
-220.78%2.89%-
SEC Filings: 10-K · 10-Q